Cargando…
Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129595/ https://www.ncbi.nlm.nih.gov/pubmed/27903291 http://dx.doi.org/10.1186/s13045-016-0364-0 |
| _version_ | 1782470618306838528 |
|---|---|
| author | Laszlo, George S. Alonzo, Todd A. Gudgeon, Chelsea J. Harrington, Kimberly H. Kentsis, Alex Gerbing, Robert B. Wang, Yi-Cheng Ries, Rhonda E. Raimondi, Susana C. Hirsch, Betsy A. Gamis, Alan S. Meshinchi, Soheil Walter, Roland B. |
| author_facet | Laszlo, George S. Alonzo, Todd A. Gudgeon, Chelsea J. Harrington, Kimberly H. Kentsis, Alex Gerbing, Robert B. Wang, Yi-Cheng Ries, Rhonda E. Raimondi, Susana C. Hirsch, Betsy A. Gamis, Alan S. Meshinchi, Soheil Walter, Roland B. |
| author_sort | Laszlo, George S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5129595 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51295952016-12-12 Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group Laszlo, George S. Alonzo, Todd A. Gudgeon, Chelsea J. Harrington, Kimberly H. Kentsis, Alex Gerbing, Robert B. Wang, Yi-Cheng Ries, Rhonda E. Raimondi, Susana C. Hirsch, Betsy A. Gamis, Alan S. Meshinchi, Soheil Walter, Roland B. J Hematol Oncol Erratum BioMed Central 2016-11-30 /pmc/articles/PMC5129595/ /pubmed/27903291 http://dx.doi.org/10.1186/s13045-016-0364-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Laszlo, George S. Alonzo, Todd A. Gudgeon, Chelsea J. Harrington, Kimberly H. Kentsis, Alex Gerbing, Robert B. Wang, Yi-Cheng Ries, Rhonda E. Raimondi, Susana C. Hirsch, Betsy A. Gamis, Alan S. Meshinchi, Soheil Walter, Roland B. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title | Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title_full | Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title_fullStr | Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title_full_unstemmed | Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title_short | Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group |
| title_sort | erratum to: high expression of myocyte enhancer factor 2c (mef2c) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the children’s oncology group |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129595/ https://www.ncbi.nlm.nih.gov/pubmed/27903291 http://dx.doi.org/10.1186/s13045-016-0364-0 |
| work_keys_str_mv | AT laszlogeorges erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT alonzotodda erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT gudgeonchelseaj erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT harringtonkimberlyh erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT kentsisalex erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT gerbingrobertb erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT wangyicheng erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT riesrhondae erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT raimondisusanac erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT hirschbetsya erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT gamisalans erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT meshinchisoheil erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup AT walterrolandb erratumtohighexpressionofmyocyteenhancerfactor2cmef2cisassociatedwithadverseriskfeaturesandpooroutcomeinpediatricacutemyeloidleukemiaareportfromthechildrensoncologygroup |